Skip to main content
Livermore
Livermore
ZHEN

Birchview Capital, LP

SEC CIK
0001618205
Latest filing
Aug 14, 2026

KALV holding history

KalVista Pharmaceuticals, Inc. in every 13F filed by Birchview Capital, LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

KALV overviewAll 13F holders of KALVFull Q2 2026 holdings

Shares (Q2 2026)
0
Sold out in Q2 2026
Value
$0
% of portfolio
0.0%
Quarters held
21
Since Q1 2021
Holdings of KALV by Birchview Capital, LP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20260$00.0%−57,000−100.0%Sold outHolders
Q1 202657,000$1.15M0.7%00.0%UnchangedHolders
Q4 202557,000$920.5K0.5%−10,000−14.9%ReducedHolders
Q3 202567,000$816.1K0.6%00.0%UnchangedHolders
Q2 202567,000$757.4K0.8%−20.0%ReducedHolders
Q1 202567,002$773.2K0.7%+20.0%AddedHolders
Q4 202467,000$567.5K0.5%−15,000−18.3%ReducedHolders
Q3 202482,000$949.6K0.8%+36,000+78.3%AddedHolders
Q2 202446,000$541.9K0.5%00.0%UnchangedHolders
Q1 202446,000$545.6K0.4%+6,000+15.0%AddedHolders
Q4 202340,000$490.0K0.4%00.0%UnchangedHolders
Q3 202340,000$385.2K0.3%00.0%UnchangedHolders
Q2 202340,000$360.0K0.3%00.0%UnchangedHolders
Q1 202340,000$314.0K0.2%00.0%UnchangedHolders
Q4 202240,000$270.0K0.2%00.0%UnchangedHolders
Q3 202240,000$580.0K0.4%00.0%UnchangedHolders
Q2 202240,000$394.0K0.3%00.0%UnchangedHolders
Q1 202240,000$590.0K0.4%00.0%UnchangedHolders
Q4 202140,000$529.0K0.3%00.0%UnchangedHolders
Q3 202140,000$698.0K0.5%00.0%UnchangedHolders
Q2 202140,000$958.0K0.6%00.0%UnchangedHolders
Q1 202140,000$1.03M0.6%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.